Literature DB >> 25466607

Mobile phone and cordless phone use and the risk for glioma - Analysis of pooled case-control studies in Sweden, 1997-2003 and 2007-2009.

Lennart Hardell1, Michael Carlberg2.   

Abstract

We made a pooled analysis of two case-control studies on malignant brain tumours with patients diagnosed during 1997-2003 and 2007-2009. They were aged 20-80 years and 18-75 years, respectively, at the time of diagnosis. Only cases with histopathological verification of the tumour were included. Population-based controls, matched on age and gender, were used. Exposures were assessed by questionnaire. The whole reference group was used in the unconditional regression analysis adjusted for gender, age, year of diagnosis, and socio-economic index. In total, 1498 (89%) cases and 3530 (87%) controls participated. Mobile phone use increased the risk of glioma, OR=1.3, 95% CI=1.1-1.6 overall, increasing to OR=3.0, 95% CI=1.7-5.2 in the >25 year latency group. Use of cordless phones increased the risk to OR=1.4, 95% CI=1.1-1.7, with highest risk in the >15-20 years latency group yielding OR=1.7, 95% CI=1.1-2.5. The OR increased statistically significant both per 100h of cumulative use, and per year of latency for mobile and cordless phone use. Highest ORs overall were found for ipsilateral mobile or cordless phone use, OR=1.8, 95% CI=1.4-2.2 and OR=1.7, 95% CI=1.3-2.1, respectively. The highest risk was found for glioma in the temporal lobe. First use of mobile or cordless phone before the age of 20 gave higher OR for glioma than in later age groups.
Copyright © 2014 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  25 years latency; Glioma; Ipsilateral; Time since first exposure; Wireless phones

Year:  2014        PMID: 25466607     DOI: 10.1016/j.pathophys.2014.10.001

Source DB:  PubMed          Journal:  Pathophysiology        ISSN: 0928-4680


  31 in total

1.  Probabilistic Multiple-Bias Modeling Applied to the Canadian Data From the Interphone Study of Mobile Phone Use and Risk of Glioma, Meningioma, Acoustic Neuroma, and Parotid Gland Tumors.

Authors:  F Momoli; J Siemiatycki; M L McBride; M-É Parent; L Richardson; D Bedard; R Platt; M Vrijheid; E Cardis; D Krewski
Journal:  Am J Epidemiol       Date:  2017-10-01       Impact factor: 4.897

2.  Genetic susceptibility may modify the association between cell phone use and thyroid cancer: A population-based case-control study in Connecticut.

Authors:  Jiajun Luo; Hang Li; Nicole C Deziel; Huang Huang; Nan Zhao; Shuangge Ma; Xin Ni; Robert Udelsman; Yawei Zhang
Journal:  Environ Res       Date:  2019-12-06       Impact factor: 6.498

3.  Hypofractionated radiation therapy with temozolomide versus standard chemoradiation in patients with glioblastoma multiforme (GBM): A prospective, single institution experience.

Authors:  Amal Rayan; Samya Abdel-Kareem; Huda Hasan; Asmaa M Zahran; Doaa A Gamal
Journal:  Rep Pract Oncol Radiother       Date:  2020-08-25

4.  Cellular Telephone Use and the Risk of Brain Tumors: Update of the UK Million Women Study.

Authors:  Joachim Schüz; Kirstin Pirie; Gillian K Reeves; Sarah Floud; Valerie Beral
Journal:  J Natl Cancer Inst       Date:  2022-05-09       Impact factor: 11.816

Review 5.  Mobile phone use and risk for intracranial tumors.

Authors:  George A Alexiou; Chrissa Sioka
Journal:  J Negat Results Biomed       Date:  2015-12-23

6.  Increasing rates of brain tumours in the Swedish national inpatient register and the causes of death register.

Authors:  Lennart Hardell; Michael Carlberg
Journal:  Int J Environ Res Public Health       Date:  2015-04-03       Impact factor: 3.390

7.  Incidence of Benign Meningiomas in the United States: Current and Future Trends.

Authors:  Sonia Bhala; Douglas R Stewart; Victoria Kennerley; Valentina I Petkov; Philip S Rosenberg; Ana F Best
Journal:  JNCI Cancer Spectr       Date:  2021-04-08

Review 8.  Health Council of the Netherlands and evaluation of the fifth generation, 5G, for wireless communication and cancer risks.

Authors:  Lennart Hardell
Journal:  World J Clin Oncol       Date:  2021-06-24

9.  Analysis of gene expression in mouse brain regions after exposure to 1.9 GHz radiofrequency fields.

Authors:  James P McNamee; Pascale V Bellier; Anne T M Konkle; Reuben Thomas; Siriwat Wasoontarajaroen; Eric Lemay; Greg B Gajda
Journal:  Int J Radiat Biol       Date:  2016-03-30       Impact factor: 2.694

Review 10.  Review of the Evidence that Transcranial Electromagnetic Treatment will be a Safe and Effective Therapeutic Against Alzheimer's Disease.

Authors:  Gary W Arendash
Journal:  J Alzheimers Dis       Date:  2016-05-30       Impact factor: 4.472

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.